UNICA IRIS Institutional Research Information System

KOWALIK, MARTA ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 90.918
NA - Nord America 2.535
AS - Asia 464
AF - Africa 9
SA - Sud America 9
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 93.939
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 90.229
US - Stati Uniti d'America 2.514
CN - Cina 237
SE - Svezia 233
UA - Ucraina 144
DE - Germania 117
SG - Singapore 91
GB - Regno Unito 65
FI - Finlandia 45
VN - Vietnam 28
TR - Turchia 27
BE - Belgio 20
CA - Canada 20
IR - Iran 18
FR - Francia 17
KR - Corea 17
IN - India 11
RU - Federazione Russa 9
MY - Malesia 7
ZA - Sudafrica 7
JP - Giappone 6
BR - Brasile 5
CH - Svizzera 5
ES - Italia 5
TW - Taiwan 5
IE - Irlanda 4
IL - Israele 4
LT - Lituania 4
MT - Malta 4
NL - Olanda 4
AU - Australia 3
BD - Bangladesh 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
CO - Colombia 2
DK - Danimarca 2
HK - Hong Kong 2
PE - Perù 2
PT - Portogallo 2
AL - Albania 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PK - Pakistan 1
SA - Arabia Saudita 1
TM - Turkmenistan 1
Totale 93.939
Salva come PNG Salva come JPEG
Città #
Cagliari 88.453
Uta 1.560
Fairfield 328
Woodbridge 216
Chandler 202
Ashburn 188
Nyköping 180
Houston 154
Ann Arbor 150
Boardman 144
Seattle 116
Wilmington 115
Cambridge 105
Dearborn 82
Jacksonville 64
Singapore 52
Santa Clara 49
Shanghai 38
Los Angeles 33
Beijing 32
Nanjing 31
Dong Ket 28
Helsinki 24
Redwood City 23
Brussels 20
Kocaeli 19
San Mateo 19
New York 18
Boston 17
Milan 16
San Diego 15
Toronto 15
Guangzhou 14
Seoul 14
Falls Church 12
London 12
Jiaxing 11
Mountain View 11
Rome 11
Frankfurt am Main 10
Nanchang 10
Bari 9
Shenyang 8
Bogazici 7
Changsha 7
Leawood 7
Norwalk 7
Pisa 7
Auburn Hills 6
Augusta 6
Hefei 6
Milwaukee 6
Orange 6
Pune 6
Ardabil 5
Atlanta 5
Florence 5
Millbury 5
Phoenix 5
Ploaghe 5
Columbus 4
Dublin 4
Hebei 4
Luras 4
Madrid 4
Melita 4
Monmouth Junction 4
Monserrato 4
Pretoria 4
Quartu Sant'elena 4
Sassari 4
Shenzhen 4
Verona 4
Wuhan 4
Zhengzhou 4
Bologna 3
Chicago 3
Curitiba 3
Durban 3
Jinan 3
Kobe 3
Livorno 3
Munich 3
Ningbo 3
Ottawa 3
Paris 3
Selargius 3
Tianjin 3
Turin 3
Washington 3
Zurich 3
Azzano Decimo 2
Bayan Lepas 2
Bergamo 2
Bogotá 2
Buffalo 2
Chengdu 2
Clauzetto 2
Dhaka 2
Hong Kong 2
Totale 92.855
Salva come PNG Salva come JPEG
Nome #
Thyroid hormone receptor ligands induce regression of rat preneoplastic liver lesions causing their reversion to a differentiated phenotype 5.895
Expression of c-jun is not mandatory for mouse hepatocyte proliferation induced by two nuclear receptor ligands: TCPOBOP and T3 4.850
Statistical health monitoring applied to a metabolomic study of experimental hepatocarcinogenesis: an alternative approach to supervised methods for the identification of false positives 4.127
Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice 4.093
YAP activation is an early event and a potential therapeutic target in liver cancer development 3.892
Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats 3.780
Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats 3.716
TRbeta is the critical thyroid hormone receptor isoform in T3-induced proliferation of hepatocytes and pancreatic acinar cells 3.620
Cytokeratin-19 positivity is acquired along cancer progression and does not predict cell origin in rat hepatocarcinogenesis 3.570
Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis 3.527
Emerging role of the pentose phosphate pathway in hepatocellular carcinoma 3.479
Global gene expression profile of normal and regenerating liver in young and old mice 3.438
Transcription profiling by array of mouse liver from TCPOBOP treated wild type and c-jun conditional knockout animals. 3.346
MicroRNA/gene profiling unveils early molecular changes and nuclear factor erythroid related factor 2 (NRF2) activation in a rat model recapitulating human hepatocellular carcinoma (HCC). 3.040
Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis 3.032
Induction of autophagy promotes the growth of early preneoplastic rat liver nodules 2.932
Reply to: "YAP in tumorigenesis: Friend or foe?" 2.679
High frequency of β-catenin mutations in mouse hepatocellular carcinomas induced by a nongenotoxic constitutive androstane receptor agonist 2.525
Reply to: Clinical correlation of miR-375 and alpha-fetoprotein in hepatocellular carcinoma: comparison in mice and humans 2.276
Accelerated entry into S phase and increased hepatocyte proliferation in c-jun conditional knock-out mice following administration of the CAR agonist TCPOBOP 2.268
Thyroid hormones, thyromimetics and their metabolites in the treatment of liver disease 2.228
Gender-specific interplay of signaling through β-catenin and CAR in the regulation of xenobiotic-induced hepatocyte proliferation 2.051
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience 1.849
Animal models: A useful tool to unveil metabolic changes in hepatocellular carcinoma 1.523
Early metabolic changes in a liver carcinogenesis model 1.395
Design, synthesis and biological evaluation of novel TRβ selective agonists sustained by ADME-toxicity analysis 1.339
Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection 1.278
Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming 1.106
Early Metabolic Changes in preneoplastc nodules of the liver 1.074
Potential role of two novel agonists of thyroid hormone receptor-β on liver regeneration 825
Tg68, a novel thyroid hormone receptor‐β agonist for the treatment of NAFLD 822
Effect of the ligands of thyroid hormone receptor on non-alcoholic fatty liver disease 754
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC 715
The density of hepatic autonomic innervation differs between compensatory and direct hyperplasia rat models 708
Distinct Mechanisms Are Responsible for Nrf2-Keap1 Pathway Activation at Different Stages of Rat Hepatocarcinogenesis 684
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 649
The double-sided of human leukocyte antigen-G molecules in type 1 autoimmune hepatitis 647
Delta-globin gene expression improves sickle cell disease in a humanised mouse model 552
mRNA-miRNA networks identify metabolic pathways associated to the anti-tumorigenic effect of thyroid hormone on preneoplastic nodules and hepatocellular carcinoma 526
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 498
Diverse MicroRNAs-mRNA networks regulate the priming phase of mouse liver regeneration and of direct hyperplasia 385
THYROID HORMONE INHIBITS HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT BY INTERFERING WITH THE METABOLIC PROFILE OF CANCER CELLS 366
Multi-Organ Morphological Findings in a Humanized Murine Model of Sickle Cell Trait 354
Characterization Of Early Stage Metabolic Perturbations In A Rat Model Of Hepatocellular Carcinogenesis 343
Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma 332
Novel thyroid hormone receptor beta agonist TG68 safely induces hepatic fat loss reduction in a NASH mouse model 311
Novel thyroid hormone receptor-beta agonist TG68 safely induces hepatic fat reduction in a non-alcoholic steatohepatitis rat model 303
Potential use of TG68 - A novel thyromimetic - for the treatment of non-alcoholic fatty liver (NAFLD)-associated hepatocarcinogenesis 227
Metabolic reprogramming in Nrf2-driven proliferation of normal rat hepatocytes 177
Totale 94.106
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.836
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.836
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.192 0 0 0 0 0 3.851 2.053 472 272 370 395 779
2020/202119.275 546 832 750 5.699 3.354 2.054 1.286 1.207 610 1.157 1.171 609
2021/20225.325 767 352 233 343 519 371 210 192 545 575 609 609
2022/20237.951 462 877 1.022 712 636 885 514 464 527 651 792 409
2023/20247.638 475 253 275 387 737 1.172 1.336 688 354 446 638 877
2024/202518.758 7.396 7.556 1.492 1.484 689 141 0 0 0 0 0 0
Totale 94.106